ClinicalTrials.gg
Drug

Copanlisib clinical trials

Also written BAY 80-6946 and Aliqopa.

Includes 9 studies of Copanlisib hydrochloride.

studies test it
67
open now
0
in phase 3
3
first study started
2009

How each study uses copanlisib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
14 Sept 2017 · ALIQOPA · NDA 209936 (FDA, Drugs@FDA; as copanlisib hydrochloride)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Copanlisib
42
PI3K Inhibitor BAY 80-6946
13
Copanlisib (Aliqopa, BAY80-6946)
7
Copanlisib (BAY80-6946)
7
BAY 80 6946
4

Brand

Aliqopa
11

Development codes

BAY 80-6946
19

Studies by the year they started

67 studies that test it; most in 2018 (11)

Studies that test copanlisib, by start year
YearStudies
20091
20112
20121
20143
20156
20166
20172
201811
201911
202011
20216
20225
20241
20251

Who runs them

Industry 18 · Other 49

Bayer (18) · National Cancer Institute (NCI) (16) · Memorial Sloan Kettering Cancer Center (4) · City of Hope Medical Center (2) · M.D. Anderson Cancer Center (2) · Cancer Trials Ireland (2) · Columbia University (2) · University of Washington (2)

Often tested with

Tested in the same studies.

Nivolumab (7) · Rituximab (5) · Venetoclax (3) · Ibrutinib (3) · Gemcitabine (2) · Fulvestrant (2) · Adavosertib (1) · Afatinib (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test copanlisib.

Studies

Open first, then newest update. How each study uses copanlisib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 67

See all 67 studies that test copanlisib →

Given beside what is tested · 4 — copanlisib is usual care or a partner of the new treatment

Codes

What other systems call copanlisib · ClinicalTrials.gg INT000019

  • MeSH (NLM) C000589253copanlisibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) WI6V529FZ9COPANLISIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1945077One source FDA
  • Wikidata Q19903876copanlisibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C96796CopanlisibOne source FDA
  • DrugBank DB12483One source Wikidata

Also registered as copanlisib hydrochloride hydrate (UNII W421JK3CPA).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.